Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | USP2 | O75604 | 1/20 | 0.66 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.66 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.66 |
| ▸ | ARNT | P27540 | 12/20 | 0.59 |
| ▸ | EPAS1 | Q99814 | 12/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7073313 | 0.81 | KMT2A (0.68) | MEN1KMT2AUSP2KEAP1NFE2L2 | |
| SCHEMBL3503925 | 0.79 | KMT2A (1.00) | MEN1KMT2AUSP2KEAP1NFE2L2 | |
| SCHEMBL28411867 | 0.79 | KMT2A (0.71) | MEN1KMT2AUSP2KEAP1NFE2L2 | |
| SCHEMBL15716688 | 0.79 | KMT2A (1.00) | MEN1KMT2AUSP2KEAP1NFE2L2 | |
| SCHEMBL7089706 | 0.79 | MEN1 (0.66) | MEN1KMT2AUSP2KEAP1NFE2L2 | |
| SCHEMBL16111786 | 0.79 | KMT2A (0.66) | MEN1KMT2AUSP2KEAP1NFE2L2 | |
| SCHEMBL4370339 | 0.76 | KMT2A (0.53) | MEN1KMT2AUSP2KEAP1NFE2L2 | |
| SCHEMBL15739998 | 0.76 | ARNT (1.00) | MEN1KMT2AARNTEPAS1MAPT | |
| SCHEMBL15740114 | 0.75 | MAPT (0.77) | MEN1KMT2AARNTEPAS1MAPT | |
| SCHEMBL15740116 | 0.75 | ARNT (0.79) | MEN1KMT2AARNTEPAS1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7539006-B2 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2009-05-26 | — | — | US | claimed |
| US-20070029529-A1 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | KOMATSU AKIHIKO | 2007-02-08 | — | — | US | claimed |
| US-20040245105-A1 | Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2004-12-09 | — | — | US | claimed |
| EP-1437749-A1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2004-07-14 | — | — | EP | claimed |
| WO-2024090399-A1 | METHOD FOR DETECTING TEST SUBSTANCE IN SPECIMEN | 地方独立行政法人東京都健康長寿医療センター | 2024-05-02 | — | — | WO | disclosed |
| EP-1052510-B2 | NOVEL COMPLEXES CONTAINING CROSSLINKED AVIDIN, PROCESS FOR PREPARING AND ANALYTICAL METHOD USING THE SAME | LSI MEDIENCE CORP (JP) | 2018-08-01 | — | — | EP | disclosed |
| US-7539006-B2 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2009-05-26 | — | — | US | disclosed |
| US-20070029529-A1 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | KOMATSU AKIHIKO | 2007-02-08 | — | — | US | disclosed |
| EP-1052510-B1 | NOVEL COMPLEXES CONTAINING CROSSLINKED AVIDIN, PROCESS FOR PREPARING AND ANALYTICAL METHOD USING THE SAME | MITSUBISHI KAGAKU IATRON INC (JP) | 2006-05-24 | — | — | EP | disclosed |
| US-20040245105-A1 | Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2004-12-09 | — | — | US | disclosed |
| US-6787325-B1 | Complexes containing crosslinked avidin, analytical method with the use of crosslinked avidin and analytical reagents and kits | IATRON LABORATORIES, INC. (JP) | 2004-09-07 | — | — | US | disclosed |
| EP-1437749-A1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2004-07-14 | — | — | EP | disclosed |
| EP-1052510-A1 | NOVEL COMPLEXES CONTAINING CROSSLINKED AVIDIN, ANALYTICAL METHOD WITH THE USE OF CROSSLINKED AVIDIN AND ANALYTICAL REAGENTS AND KITS | IATRON LABORATORIES, INC. (JP) | 2000-11-15 | — | — | EP | disclosed |